1. Home
  2. DYNC vs PRQR Comparison

DYNC vs PRQR Comparison

Compare DYNC & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynamix Corporation Class A Ordinary Shares

DYNC

Dynamix Corporation Class A Ordinary Shares

N/A

Current Price

$10.91

Market Cap

238.8M

Sector

N/A

ML Signal

N/A

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

N/A

Current Price

$1.63

Market Cap

262.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DYNC
PRQR
Founded
2024
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.8M
262.5M
IPO Year
2024
2014

Fundamental Metrics

Financial Performance
Metric
DYNC
PRQR
Price
$10.91
$1.63
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $8.22
AVG Volume (30 Days)
32.3K
★ 511.7K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.20
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.76
$1.33
52 Week High
$10.99
$3.10

Technical Indicators

Market Signals
Indicator
DYNC
PRQR
Relative Strength Index (RSI) 52.32 31.81
Support Level $10.76 $1.64
Resistance Level $10.97 $1.99
Average True Range (ATR) 0.02 0.08
MACD -0.00 -0.02
Stochastic Oscillator 50.00 10.00

Price Performance

Historical Comparison
DYNC
PRQR

About DYNC Dynamix Corporation Class A Ordinary Shares

Dynamix Corp is a blank check company.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: